Similar Articles
491 Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma
492 Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
493 Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
494 Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
495 Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?
496 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways
497 Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment
498 Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
499 Targets of immunotherapy for hepatocellular carcinoma: An update
500 Application value of mixed reality in hepatectomy for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA